|
| | Publication Year | Title | Author(s) |
| 1 | 18-Jul-2022 | Clinical Assessment for Pulmonary Hypertension in Interstitial Lung Disease. | Chan, Roseanne Kimberley; Horrigan, Mark ; Goh, Nicole S L ; Khor, Yet Hong |
| 2 | 31-Jan-2022 | Reperfusion times and outcomes in patients with ST-elevation myocardial infarction presenting without pre-hospital notification. | Hamilton, Garry W ; Yeoh, Julian; Dinh, Diem; Brennan, Angela; Yudi, Matias B ; Freeman, Melanie; Horrigan, Mark ; Martin, Lorelle ; Reid, Christopher M; Yip, Thomas; Picardo, Sandra; Sharma, Anand; Duffy, Stephen J; Farouque, Omar ; Clark, David J ; Ajani, Andrew E |
| 3 | Oct-2021 | Two-year outcomes from the MitrAl ValvE RepaIr Clinical (MAVERIC) trial: a novel percutaneous treatment of functional mitral regurgitation. | Patterson, Tiffany; Gregson, John; Erglis, Andrejs; Joseph, Jubin; Rajani, Ronak; Wilson, Karen; Prendergast, Bernard; Worthley, Stephen; Hildick-Smith, David; Rafter, Tony; Whelan, Alan; De Marco, Federico; Horrigan, Mark ; Redwood, Simon R |
| 4 | Sep-2021 | Safety and Long-Term Clinical Outcomes of Fractional Flow Reserve Guided Coronary Revascularisation. | Scully, Timothy G; Toner, Liam ; Yeoh, Julian; Farouque, Omar ; Yudi, Matias B ; Horrigan, Mark ; Clark, David J |
| 5 | 6-Aug-2021 | Two-year outcomes from the MitrAl Valve rEpaiR Clinical (MAVERIC) Trial: a novel percutaneous treatment of functional mitral regurgitation. | Patterson, T ; Gregson, J; Erglis, A; Joseph, J ; Rajani, R; Wilson, K; Prendergast, B; Worthley, S; Hildick-Smith, D; Rafter, T; Whelan, A; De Marco, F; Horrigan, Mark ; Redwood, S R |
| 6 | Jul-2021 | Cardiac risk stratification in liver transplantation: results of a tiered assessment protocol based on traditional cardiovascular risk factors. | Robertson, Marcus ; Chung, William ; Liu, Dorothy ; Seagar, Rosemary; O'Halloran, Tess; Koshy, Anoop N ; Horrigan, Mark ; Farouque, Omar ; Gow, Paul J ; Angus, Peter W |
| 7 | 1-Jan-2021 | Transcatheter aortic valve replacement in patients with a history of cancer: Periprocedural and long-term outcomes. | Murphy, Alexandra C ; Koshy, Anoop N ; Cameron, William; Horrigan, Mark ; Kearney, Leighton; Yeo, Belinda ; Farouque, Omar ; Yudi, Matias B |
| 8 | Jan-2021 | Postoperative Atrial Fibrillation and Long-Term Risk of Stroke in Patients Undergoing Liver Transplantation. | Koshy, Anoop N ; Enayati, Anees ; Weinberg, Laurence ; Han, Hui-Chen ; Horrigan, Mark ; Gow, Paul J ; Ko, Jefferson ; Thijs, Vincent N ; Testro, Adam G ; Lim, Han S ; Farouque, Omar ; Teh, Andrew W |
| 9 | Oct-2020 | Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and Challenges. | Anderson, James; Lavender, Melanie; Lau, Edmund; Celermajer, David; Collins, Nicholas; Dwyer, Nathan; Feenstra, John; Horrigan, Mark ; Keating, Dominic; Keogh, Anne; Kotlyar, Eugene; Ng, Benjamin; Proudman, Susanna; Steele, Peter; Thakkar, Vivek; Weintraub, Robert; Whitford, Helen; Williams, Trevor; Wrobel, Jeremy; Strange, Geoff |
| 10 | Oct-2020 | Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients. | Koshy, Anoop N ; Murphy, Alexandra C ; Farouque, Omar ; Horrigan, Mark ; Yudi, Matias B |
| 11 | Aug-2020 | Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registry. | Khou, Victor; Anderson, James J; Strange, Geoff; Corrigan, Carolyn; Collins, Nicholas; Celermajer, David S; Dwyer, Nathan; Feenstra, John; Horrigan, Mark ; Keating, Dominic; Kotlyar, Eugene; Lavender, Melanie; McWilliams, Tanya J; Steele, Peter; Weintraub, Robert; Whitford, Helen; Whyte, Ken; Williams, Trevor J; Wrobel, Jeremy P; Keogh, Anne; Lau, Edmund M |
| 12 | 15-May-2020 | Meta-analysis Comparing Valve-In-Valve Transcatheter Aortic Valve Implantation With Self-Expanding Versus Balloon-Expandable Valves. | Hamilton, Garry W ; Koshy, Anoop N ; Fulcher, Jordan ; Tang, Gilbert H L; Bapat, Vinayak; Murphy, Alexandra C ; Horrigan, Mark ; Farouque, Omar ; Yudi, Matias B |
| 13 | 26-Sep-2019 | Retrospective validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort. | Anderson, James J; Lau, Edmund M; Lavender, Melanie; Benza, Raymond; Celermajer, David S; Collins, Nicholas; Corrigan, Carolyn; Dwyer, Nathan; Feenstra, John; Horrigan, Mark ; Keating, Dominic; Kermeen, Fiona; Kotlyar, Eugene; McWilliams, Tanya; Rhodes, Bronwen; Steele, Peter; Thakkar, Vivek; Williams, Trevor; Whitford, Helen; Whyte, Kenneth; Weintraub, Robert; Wrobel, Jeremy P; Keogh, Anne; Strange, Geoff |
| 14 | 9-Aug-2019 | Rare cause of pulmonary hypertension - pulmonary tumour thrombotic microangiopathy. | O'Brien, Joseph M; Jones, Nicholas ; Horrigan, Mark ; Al-Kaisey, Ahmed M |
| 15 | Dec-2018 | Feasibility of using ultra-low pulse rate fluoroscopy during routine diagnostic coronary angiography. | Badawy, Mohamed Khaldoun; Scott, Matthew; Farouque, Omar ; Horrigan, Mark ; Clark, David J ; Chan, Robert K |
| 16 | 28-Feb-2017 | Improving Guideline Compliance in Australia With a National Percutaneous Coronary Intervention Outcomes Registry. | Eccleston, David; Horrigan, Mark ; Rafter, Tony; Holt, Geoffrey; Worthley, Stephen G; Sage, Peter; Whelan, Alan; Reid, Christopher; Thompson, Peter L |
| 17 | 14-Sep-2016 | The receptor for advanced glycation end products (RAGE) is associated with persistent atrial fibrillation | Lancefield, Terase F; Patel, Sheila K ; Freeman, Melanie; Velkoska, Elena; Wai, Bryan; Srivastava, Piyush M ; Horrigan, Mark ; Farouque, Omar ; Burrell, Louise M |
| 18 | 1-Jul-2016 | Management of patients ≥85 years of age with ST-elevation myocardial infarction | Yudi, Matias B ; Jones, N ; Fernando, Dharsh; Clark, David J ; Ramchand, Jay ; Jones, Elizabeth F ; Dakis, R; Johnson, Douglas F; Chan, Robert K ; Islam, Amirul; Farouque, Omar ; Horrigan, Mark |
| 19 | 1-Jul-2009 | Advances in percutaneous treatment for adult valvular heart disease. | Wong, M C G; Clark, David J ; Horrigan, Mark ; Grube, E; Matalanis, George ; Farouque, Omar |
| 20 | 12-Oct-2005 | What is the best contemporary treatment for in-stent restenosis? | Barlis, Peter; Horrigan, Mark ; Chan, Robert K ; Ajani, Andrew E; Proimos, George; Schumer, Wendy A; van Gaal, William J; Rowe, Michael; Eccleston, David; Yan, Bryan B P; Mun Cheong, Yu; Oliver, Les E; Clark, David J |
Loading...
2
0
5
0
false